Thomas Stephen Basil
Director at CLYM
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Sep 15, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CLYMClimb Bio, Inc.Director
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice CLYMNoticeFeb 12, 2026 2026
Filed to sell 100,000 shares ($556k)
Thomas Stephen Basil, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale CLYMRoutineFeb 13, 2026 +1 day
Sold 100,000 shares at $5.29 ($529k)
Thomas Stephen Basil, Director
10b5-1 planSold 32.8% of holdings ($1.6M position)204,657 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice CLYMNoticeFeb 25, 2026 +12 days
Filed to sell 50,000 shares ($318k)
Thomas Stephen Basil, Director
10b5-1 planFiling
- 4 Form 4 sale CLYMRoutineFeb 26, 2026 +1 day
Sold 50,000 shares at $7.00 ($350k)
Thomas Stephen Basil, Director
10b5-1 planSold 24.4% of holdings ($1.4M position)154,657 shares leftFollows a Form 144Filing
- 5 Form 144 notice CLYMNoticeSep 15, 2026 +201 days
Filed to sell 100,000 shares ($1.5M)
Thomas Stephen Basil, Director
10b5-1 planFiling
- 6 Form 4 sale CLYMRoutineSep 15, 2026 same day
Sold 100,000 shares at $13.67 ($1.4M)
Thomas Stephen Basil, Director
10b5-1 planSold 17.6% of holdings ($7.8M position)467,969 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 17, 2026 | CLYM | Director | Form 4 sale | 100,000 | $1.4M | 17.6% | Routine | SEC |
| Sep 15, 2026 | Sep 15, 2026 | CLYM | Director | Form 144 notice | 100,000 | $1.5M | Notice | SEC | |
| Feb 26, 2026 | Feb 27, 2026 | CLYM | Director | Form 4 sale | 50,000 | $350k | 24.4% | Routine | SEC |
| Feb 25, 2026 | Feb 25, 2026 | CLYM | Director | Form 144 notice | 50,000 | $318k | Notice | SEC | |
| Feb 13, 2026 | Feb 17, 2026 | CLYM | Director | Form 4 sale | 100,000 | $529k | 32.8% | Routine | SEC |
| Feb 12, 2026 | Feb 12, 2026 | CLYM | Director | Form 144 notice | 100,000 | $556k | Notice | SEC |